Literature DB >> 9525359

Adverse reactions to levodopa: drug toxicity or progression of disease?

Y Agid1, T Chase, D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9525359     DOI： 10.1016/S0140-6736(05)70285-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Potential role of cannabinoids in Parkinson's disease.

Authors:  J Sevcík; K Masek
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.

Authors:  Nicholas H G Holford; Phylinda L S Chan; John G Nutt; Karl Kieburtz; Ira Shoulson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-04-20       Impact factor: 2.745

3.  Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.

Authors:  Stewart A. Factor
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

4.  Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.

Authors:  Maryam Rezaei; Masoud Alirezaei
Journal:  J Physiol Sci       Date:  2014-01-25       Impact factor: 2.781

5.  Initial treatment of Parkinson's disease.

Authors:  Daniel Tarsy
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.